Literature DB >> 33264545

"Super-Spreaders" and Person-to-Person Transmission of Andes Virus in Argentina.

Valeria P Martínez1, Nicholas Di Paola1, Daniel O Alonso1, Unai Pérez-Sautu1, Carla M Bellomo1, Ayelén A Iglesias1, Rocio M Coelho1, Beatriz López1, Natalia Periolo1, Peter A Larson1, Elyse R Nagle1, Joseph A Chitty1, Catherine B Pratt1, Jorge Díaz1, Daniel Cisterna1, Josefina Campos1, Heema Sharma1, Bonnie Dighero-Kemp1, Emiliano Biondo1, Lorena Lewis1, Constanza Anselmo1, Camila P Olivera1, Fernanda Pontoriero1, Enzo Lavarra1, Jens H Kuhn1, Teresa Strella1, Alexis Edelstein1, Miriam I Burgos1, Mario Kaler1, Adolfo Rubinstein1, Jeffrey R Kugelman1, Mariano Sanchez-Lockhart1, Claudia Perandones1, Gustavo Palacios1.   

Abstract

BACKGROUND: From November 2018 through February 2019, person-to-person transmission of Andes virus (ANDV) hantavirus pulmonary syndrome occurred in Chubut Province, Argentina, and resulted in 34 confirmed infections and 11 deaths. Understanding the genomic, epidemiologic, and clinical characteristics of person-to-person transmission of ANDV is crucial to designing effective interventions.
METHODS: Clinical and epidemiologic information was obtained by means of patient report and from public health centers. Serologic testing, contact-tracing, and next-generation sequencing were used to identify ANDV infection as the cause of this outbreak of hantavirus pulmonary syndrome and to reconstruct person-to-person transmission events.
RESULTS: After a single introduction of ANDV from a rodent reservoir into the human population, transmission was driven by 3 symptomatic persons who attended crowded social events. After 18 cases were confirmed, public health officials enforced isolation of persons with confirmed cases and self-quarantine of possible contacts; these measures most likely curtailed further spread. The median reproductive number (the number of secondary cases caused by an infected person during the infectious period) was 2.12 before the control measures were enforced and decreased to 0.96 after the measures were implemented. Full genome sequencing of the ANDV strain involved in this outbreak was performed with specimens from 27 patients and showed that the strain that was present (Epuyén/18-19) was similar to the causative strain (Epilink/96) in the first known person-to-person transmission of hantavirus pulmonary syndrome caused by ANDV, which occurred in El Bolsón, Argentina, in 1996. Clinical investigations involving patients with ANDV hantavirus pulmonary syndrome in this outbreak revealed that patients with a high viral load and liver injury were more likely than other patients to spread infection. Disease severity, genomic diversity, age, and time spent in the hospital had no clear association with secondary transmission.
CONCLUSIONS: Among patients with ANDV hantavirus pulmonary syndrome, high viral titers in combination with attendance at massive social gatherings or extensive contact among persons were associated with a higher likelihood of transmission. (Funded by the Ministerio de Salud y Desarrollo Social de la Nación Argentina and others.).
Copyright © 2020 Massachusetts Medical Society.

Entities:  

Year:  2020        PMID: 33264545     DOI: 10.1056/NEJMoa2009040

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  12 in total

1.  Evidence for Human-to-Human Transmission of Hantavirus: A Systematic Review.

Authors:  Joao Toledo; Michelle M Haby; Ludovic Reveiz; Leopoldo Sosa Leon; Rodrigo Angerami; Sylvain Aldighieri
Journal:  J Infect Dis       Date:  2022-10-17       Impact factor: 7.759

Review 2.  The kidney in hantavirus infection-epidemiology, virology, pathophysiology, clinical presentation, diagnosis and management.

Authors:  Felix C Koehler; Veronica Di Cristanziano; Martin R Späth; K Johanna R Hoyer-Allo; Manuel Wanken; Roman-Ulrich Müller; Volker Burst
Journal:  Clin Kidney J       Date:  2022-01-29

3.  Cells of the human respiratory tract support the replication of pathogenic Old World orthohantavirus Puumala.

Authors:  Stefan Hägele; Christian Nusshag; Alexander Müller; Alexandra Baumann; Martin Zeier; Ellen Krautkrämer
Journal:  Virol J       Date:  2021-08-17       Impact factor: 4.099

4.  Broad and potently neutralizing monoclonal antibodies isolated from human survivors of New World hantavirus infection.

Authors:  Taylor B Engdahl; Natalia A Kuzmina; Adam J Ronk; Chad E Mire; Matthew A Hyde; Nurgun Kose; Matthew D Josleyn; Rachel E Sutton; Apoorva Mehta; Rachael M Wolters; Nicole M Lloyd; Francisca R Valdivieso; Thomas G Ksiazek; Jay W Hooper; Alexander Bukreyev; James E Crowe
Journal:  Cell Rep       Date:  2021-05-04       Impact factor: 9.423

Review 5.  Recent Advances in Bunyavirus Glycoprotein Research: Precursor Processing, Receptor Binding and Structure.

Authors:  Ruben J G Hulswit; Guido C Paesen; Thomas A Bowden; Xiaohong Shi
Journal:  Viruses       Date:  2021-02-23       Impact factor: 5.048

Review 6.  Hantavirus Replication Cycle-An Updated Structural Virology Perspective.

Authors:  Kristina Meier; Sigurdur R Thorkelsson; Emmanuelle R J Quemin; Maria Rosenthal
Journal:  Viruses       Date:  2021-08-06       Impact factor: 5.048

7.  Emerging hantaviruses in Central Argentina: First case of Hantavirus Pulmonary Syndrome caused by Alto Paraguay virus, and a novel orthohantavirus in Scapteromys aquaticus rodent.

Authors:  Carla Bellomo; Daniel Oscar Alonso; Tamara Ricardo; Rocío Coelho; Sebastián Kehl; Natalia Periolo; Viviana Azogaray; Natalia Casas; Mariano Ottonelli; Laura Cristina Bergero; María Carolina Cudós; María Andrea Previtali; Valeria Paula Martinez
Journal:  PLoS Negl Trop Dis       Date:  2021-11-17

Review 8.  Common Themes in Zoonotic Spillover and Disease Emergence: Lessons Learned from Bat- and Rodent-Borne RNA Viruses.

Authors:  Evan P Williams; Briana M Spruill-Harrell; Mariah K Taylor; Jasper Lee; Ashley V Nywening; Zemin Yang; Jacob H Nichols; Jeremy V Camp; Robert D Owen; Colleen B Jonsson
Journal:  Viruses       Date:  2021-07-31       Impact factor: 5.048

9.  Antiviral Efficacy of Ribavirin and Favipiravir against Hantaan Virus.

Authors:  Jennifer Mayor; Olivier Engler; Sylvia Rothenberger
Journal:  Microorganisms       Date:  2021-06-15

10.  Genetic depletion studies inform receptor usage by virulent hantaviruses in human endothelial cells.

Authors:  Maria Eugenia Dieterle; Carles Solà-Riera; Chunyan Ye; Samuel M Goodfellow; Eva Mittler; Ezgi Kasikci; Steven B Bradfute; Jonas Klingström; Rohit K Jangra; Kartik Chandran
Journal:  Elife       Date:  2021-07-06       Impact factor: 8.140

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.